PedAM
Pediatric Disease Annotations & Medicines
| Disease | hypoglycemia |
| Phenotype | |diabetes |
| Sentences | 306 |
| PubMedID- 22699295 | Conclusions: the glucagon response to hypoglycemia in adolescents with type 1 diabetes is influenced by the duration of diabetes and can be lost early in the course of the disease. |
| PubMedID- 20508232 | Vessel wall stiffness was found to be increased during hypoglycemia in patients with type 1 diabetes of longer duration than those with a shorter duration of diabetes (53). |
| PubMedID- 25288675 | Conclusions: reporting of severe hypoglycemia by patients with type 1 diabetes is significantly reduced following implementation of eu driver's licensing legislation that implies withdrawal of driver's licensing in case of recurrent episodes within 1 year. |
| PubMedID- 20132542 | The proportion of type 2 diabetes patients with fear of hypoglycaemia was 50% among those on insulin and 26% among the others. |
| PubMedID- 20843971 | Among those aged <19 years with established type 1 diabetes, the overall incidence of dka and severe hypoglycemia was estimated to be 8 and 19 per 100 patient-years, respectively (2). |
| PubMedID- 24556352 | Reporting of hypoglycemia (in patients with diabetes) and falling or severe dizziness (in patients without diabetes) were most frequently paired with other adverse safety events. |
| PubMedID- 25765720 | Objective: reported rates of hypoglycemia in patients with type 2 diabetes mellitus are lower with glimepiride as compared to glyburide. |
| PubMedID- 25415670 | Seasonal variations of severe hypoglycemia in patients with type 1 diabetes mellitus, type 2 diabetes mellitus, and non-diabetes mellitus: clinical analysis of 578 hypoglycemia cases. |
| PubMedID- 22180760 | Studies using this survey have identified variables contributing to fear of hypoglycemia in children with type 1 diabetes and their parents, such as history of frequent or traumatic hypoglycemia, as well as trait anxiety. |
| PubMedID- 21525492 | hypoglycemia in patients with diabetes on antidiabetic medications who fast for laboratory tests. |
| PubMedID- 24524438 | Caution is warranted in the management of hypoglycemia in patients with diabetes with the conditions described here, that is malnutrition and immunosuppression, as infection may be a contributing factor. |
| PubMedID- 22295728 | Material and method: fifty-one type ii diabetes with severe hypoglycemia admitted between october 2006 and september 2008 and 359 nonhypoglycemic type ii diabetes were evaluated in this case-control study. |
| PubMedID- 21777428 | The primary cause of hypoglycemia among patients with type 2 diabetes is antihyperglycemic medications - in particular, those which raise insulin levels independently of blood glucose, such as sulfonylureas and insulin [6]. |
| PubMedID- 26152404 | In certain situations, it is important to recognize the possibility of non-diabetic causes of hypoglycemia in patients with diabetes and to avoid treating pseudo-hyperglycemia caused by glucose- non-specific glucometers in patients utilizing icodextrin-based solutions for peritoneal dialysis. |
| PubMedID- 22646230 | The most common causes of hypoglycemia among patients with type 2 diabetes include the use of hypoglycemic medications [4], inadequate caloric intake, exercise, errors with use of medications, and intercurrent illnesses. |
| PubMedID- 26239457 | hypoglycemia in patients with diabetes and renal disease. |
| PubMedID- 25810037 | All participants had c-peptide-negative diabetes complicated by recurrent severe hypoglycaemia (≥1 event over the preceding 12 months that required assistance) despite optimised conventional management. |
| PubMedID- 20566676 | In addition to the deleterious effect on metabolic comorbidities and for some agents an increased risk of hypoglycemia, treatment with most antidiabetes agents is further confounded by a loss of efficacy over time, in part due to the progressive worsening of diabetes characterized by insulin resistance and impaired glucose-stimulated insulin secretion (11). |
| PubMedID- 25387218 | At the same time, recent reports have alerted the medical community to the risk of hypoglycemia in patients with diabetes on antidiabetic medications (particularly insulin and sulfonylureas) who are asked to fast for lab tests. |
| PubMedID- 24641928 | Conclusion: hypoglycemia in patients with diabetes hospitalized in internal medicine wards is associated with increases in the los, inpatient mortality, and early readmission. |
| PubMedID- 23543638 | An estimated 2–4% of deaths of people with type 1 diabetes have been attributed to hypoglycemia (cryer, 2004), and hypoglycemia also occurs in type 2 diabetes with prevalence rates of 70–80% in clinical trials of insulin (ukpds, 1998; jensen et al., 2010). |
| PubMedID- 22276259 | Vessel wall stiffness was found to be increased during hypoglycemia in patients with type-1 diabetes of longer duration than those with shorter duration of diabetes. |
| PubMedID- 24965522 | Aim: to describe mood and psychosensorial symptoms of hypoglycaemia in adolescents with type 1 diabetes mellitus in two countries with different cultures, turkey and the usa. |
| PubMedID- 21971353 | Supercompensated brain glycogen may contribute to the development of hypoglycemia unawareness in patients with type 1 diabetes by providing energy for the brain during periods of hypoglycemia. |
| PubMedID- 24089545 | Association between excessive daytime sleepiness and severe hypoglycemia in people with type 2 diabetes: the edinburgh type 2 diabetes study. |
| PubMedID- 22136082 | Ketoconazole, fluconazole), act as a competitive inhibitor of the cytochrome p450 (cyp) 3a4 isoenzyme and therefore have the potential to increase the risk of hypoglycemia in people with diabetes who are taking oral hypoglycaemic medication that are metabolised by this pathway [40,53]. |
| PubMedID- 24450135 | [case report; a case of type 2 diabetes mellitus with frequent hypoglycemia due to insulin antibodies after switching insulin product]. |
| PubMedID- 22727048 | A prospective randomised cross-over study of the effect of insulin analogues and human insulin on the frequency of severe hypoglycaemia in patients with type 1 diabetes and recurrent hypoglycaemia (the hypoana trial): study rationale and design. |
| PubMedID- 24053606 | Cardiac implications of hypoglycaemia in patients with diabetes - a systematic review. |
| PubMedID- 20200306 | Even with the use of insulin pumps and long-acting insulin analogs, severe hypoglycemia is common in patients with type 1 diabetes, especially during sleep at night. |
| PubMedID- 20650471 | Conclusions: a basal insulin rate reduction was safe and effective in raising post-exercise nocturnal bg nadir and in reducing hypoglycemia in children with type 1 diabetes mellitus. |
| PubMedID- 26229454 | Significant improvements in the occurrence rate of hypoglycemia were achieved with diabetes patients in three wards of department of neurology during 2010–2013 (30.5% versus 11.3%–13.9%) (p<0.01 [chi-square test]) (figure 5). |
| PubMedID- 26338288 | Risk factors associated with hypoglycemia in patients with type 2 diabetes include old age, long disease duration, low body mass index, high baseline glycated hemoglobin (hba1c), treatment with insulin and sulphonylurea, renal dysfunction, albuminuria, reduced level of low density lipoprotein cholesterol, low triglyceride and depression. |
| PubMedID- 22357303 | Studies on nutritional strategies to prevent exercise-induced hypoglycemia in adolescents with type 1 diabetes are scarce. |
| PubMedID- 24612200 | Aims: to assess incidence rates (irs) of and identify risk factors for incident severe hypoglycaemia in patients with type 2 diabetes newly treated with antidiabetic drugs. |
| PubMedID- 24676275 | The relationship of worry about hypoglycemia with diabetes-specific and typical youth behavior among emerging adults with type 1 diabetes. |
| PubMedID- 21199269 | Aim: the objective of this systematic review and meta-analysis was to assess the effect of pramlintide on glycemic control, weight and incidence of nausea and hypoglycaemia in patients with type 2 diabetes mellitus (t2dm) and in obese patients without diabetes (obp). |
| PubMedID- 21790477 | We studied the relationship between blood and interstitial glucose during experimental hypoglycemia in subjects with type 2 diabetes treated with insulin or sulfonylureas and matched controls without diabetes. |
| PubMedID- 21826148 | The development of endogenous hyperinsulinemic hypoglycemia in patients with known diabetes is extremely rare. |
| PubMedID- 25909295 | The association of renal disease with hypoglycemia in patients with type 2 diabetes is also linked to an increased risk of cardiovascular events [46]. |
| PubMedID- 24757202 | Risk of cardiac arrhythmias during hypoglycemia in patients with type 2 diabetes and cardiovascular risk. |
| PubMedID- 25287289 | hypoglycaemia in diabetes mellitus: epidemiology and clinical implications. |
| PubMedID- 23248198 | However, recent, large, prospective, clinical trials showing the clinical outcomes of intensive glucose-lowering treatment observed increased risk of severe hypoglycemia in patients with type 2 diabetes, and hypoglycemia is regarded as the main barrier to achieving optimal glycemic targets in patients with type 2 diabetes (4–6). |
| PubMedID- 20809681 | The object of this study was to describe glucose profiles and hypoglycemia associated with hd in diabetes patients using a cgm system. |
| PubMedID- 23413806 | The preservation of insulin secretion often seen for an initial period after diagnosis of type 1 diabetes is associated with reduced hypoglycaemia and glycaemic variability, improved hba1c and lower insulin requirements [92,123]. |
| PubMedID- 24684300 | hypoglycemia associated with diabetes management is a potential risk for cardiovascular diseases. |
| PubMedID- 25985748 | We studied whether infrared thermography can detect ts changes during hypoglycaemia in patients with type 1 diabetes and how the ts response differs between patients with normal hypoglycaemia awareness and hypoglycaemia unawareness. |
| PubMedID- 24812495 | Conclusion: symptomatic hypoglycemia in patients with type 2 diabetes on metformin and sulfonylureas was associated with nonadherence and decreased treatment satisfaction despite lower mean hba1c values. |
| PubMedID- 21737469 | We selected for inclusion only studies that were randomised controlled trials and that compared glycaemic control and hypoglycaemia in participants with type 1 diabetes treated by intensive insulin therapy (multiple daily insulin injections or continuous subcutaneous insulin infusion) where either real time continuous glucose monitoring or self monitoring of blood glucose was used throughout the study for at least two months. |
| PubMedID- 23043166 | Conclusions: insulins degludec and glargine administered once daily in combination with oads provided similar long-term glycemic control in insulin-naive patients with type 2 diabetes, with lower rates of nocturnal hypoglycemia with degludec. |